Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Via Ritzau
via.ritzau.dk > pressemeddelelse > 15/14/8375 > inventiva

INVENTIVA | Globenewswire

4+ day, 23+ hour ago   (121+ words) Inventiva to Present Multiple Abstracts at Paris MASH 2026 Lanifibranor is currently being evaluated in the Phase 3 NATiV3 clinical trial for the treatment of patients with MASH with moderate and advanced fibrosis, with topline results expected in the fourth quarter of this…...

Google News
via.ritzau.dk > pressemeddelelse > 15/11/1406 > lakefront-biotherapeutics

Lakefront Biotherapeutics | Globenewswire

2+ week, 5+ day ago   (89+ words) U.S. FDA Grants Orphan Drug Designation to Gamgertamig for the Treatment of Pemphigus Gamgertamig is being developed by Lakefront in collaboration with Gilead Sciences. Ongoing clinical trials in autoimmune diseases are actively enrolling, and expansion of the clinical trials program is…...